provincial level CIP · Taizhou, Jiangsu

Taizhou (Jiangsu) Chemical Industrial Park

泰州（江苏）化工产业园

Know what the park makes, who runs the lines, and how the cargo gets to the port.

Taizhou (Jiangsu) is China's pharmaceutical-manufacturing capital, hosting Yangtze Pharmaceutical Group, Hisun Pharmaceutical, and dozens of API and pharmaceutical-intermediate plants. The chemical-park designation here reflects a pharmaceutical-intermediates economy more than a traditional petrochemical economy: the largest tenant is Yangtze Pharmaceutical (a major Chinese generic API supplier with statin, cardiovascular, and oncology actives), supplemented by Taixing Yang for pesticide intermediates and various specialty-chemistry plants. The post-Xiangshui regulatory tightening in Jiangsu hit the pesticide and dye sub-clusters hardest but largely spared the pharmaceutical-API plants because pharmaceutical-grade chemistry already operated under tighter MEE compliance baseline. Two operator-distinct points. First, Taizhou-sourced pharmaceutical intermediates carry the highest-quality regulatory-compliance documentation among Chinese fine-chemistry origins; the city has been investing in cGMP (current Good Manufacturing Practice) infrastructure since the mid-2000s. Second, US FDA and EU EMA inspections of Taizhou-area API plants are routine, which makes the city's pharmaceutical exports preferred for regulated pharmaceutical-buyer markets.